BioCardia, Inc. (BCDAD) financial statements (2020 and earlier)
Company profile
| Business Address |
125 SHOREWAY ROAD SAN CARLOS, CA 94070 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 9 | 5 | 13 | 21 | 14 | 14 | 13 | ||
| Cash and cash equivalents | 9 | 5 | 13 | 21 | 14 | 14 | 13 | ||
| Receivables | 0 | 0 | 0 | 0 | |||||
| Inventory, net of allowances, customer advances and progress billings | 0 | 0 | 0 | 0 | ✕ | ||||
| Inventory | 0 | 0 | 0 | 0 | |||||
| Prepaid expense | 0 | 0 | 0 | ||||||
| Other undisclosed current assets | 0 | ||||||||
| Total current assets: | 9 | 6 | 13 | 22 | 14 | 14 | 13 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 0 | 0 | 0 | 0 | |||||
| Other noncurrent assets | 0 | 0 | 0 | 0 | |||||
| Total noncurrent assets: | 1 | 0 | 0 | 0 | |||||
| Other undisclosed assets | 0 | 0 | 0 | ||||||
| TOTAL ASSETS: | 11 | 6 | 14 | 22 | 14 | 14 | 13 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1 | 2 | 1 | 1 | 0 | 0 | 0 | ||
| Accounts payable | 1 | 1 | 1 | 1 | |||||
| Accrued liabilities | 0 | 0 | 1 | 1 | |||||
| Other undisclosed accounts payable and accrued liabilities | 0 | 0 | 0 | ||||||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 1 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | |||||
| Customer advances and deposits | ✕ | ✕ | 0 | ✕ | |||||
| Contract with customer, liability | ✕ | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 2 | 1 | 1 | 0 | |||||
| Total current liabilities: | 4 | 3 | 2 | 1 | 0 | 0 | 0 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1 | ||||||||
| Operating lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 1 | 0 | 0 | 0 | |||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | |||||
| Deferred revenue | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Total noncurrent liabilities: | 1 | 0 | 0 | 0 | |||||
| Total liabilities: | 5 | 3 | 2 | 2 | 0 | 0 | 0 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 5 | 4 | 11 | 21 | 14 | 14 | 13 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 103 | 90 | 84 | 80 | 26 | 26 | 26 | ||
| Accumulated deficit | (98) | (86) | (72) | (60) | (12) | (12) | (13) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | ||||||||
| Total stockholders' equity: | 5 | 4 | 11 | 21 | 14 | 14 | 13 | ||
| TOTAL LIABILITIES AND EQUITY: | 11 | 6 | 14 | 22 | 14 | 14 | 13 | ||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1 | 1 | 0 | 1 | 1 | 0 | 0 | |
| Revenue, net | ✕ | ✕ | 0 | 1 | 1 | 0 | 0 | |
| Other operating income | 0 | 0 | ||||||
| Cost of revenue (Cost of Goods and Services Sold) | (0) | (1) | (1) | (1) | ||||
| Gross profit: | 0 | 0 | (0) | (0) | 1 | 0 | 0 | |
| Operating expenses | (14) | (14) | (12) | (7) | (0) | (0) | (0) | |
| Other operating income, net | 0 | 0 | ||||||
| Other undisclosed operating loss | (0) | (0) | ||||||
| Operating income (loss): | (14) | (14) | (12) | (8) | 0 | 0 | 0 | |
| Nonoperating income (expense) | (1) | 0 | 0 | (3) | ||||
| Interest and debt expense | (1) | (2) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (15) | (14) | (12) | (12) | 0 | 0 | 0 | |
| Other undisclosed income from continuing operations before income taxes | 0 | 0 | 0 | |||||
| Net income (loss): | (15) | (14) | (12) | (12) | 0 | 0 | 0 | |
| Other undisclosed net income attributable to parent | 1 | 2 | ||||||
| Net income (loss) available to common stockholders, diluted: | (15) | (14) | (12) | (10) | 0 | 0 | 0 | |
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (15) | (14) | (12) | (12) | 0 | 0 | 0 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (15) | (14) | (12) | (12) | 0 | 0 | 0 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.